home *** CD-ROM | disk | FTP | other *** search
- Path: sparky!uunet!ogicse!hp-cv!sdd.hp.com!zaphod.mps.ohio-state.edu!cs.utexas.edu!unisql!collene
- From: collene@unisql.UUCP (Collene Pearce)
- Newsgroups: sci.med
- Subject: Re: depo provera LONG
- Message-ID: <4147@unisql.UUCP>
- Date: 6 Nov 92 19:31:28 GMT
- Article-I.D.: unisql.4147
- References: <68872@cup.portal.com> <168968A84.SURGDM@mizzou1.missouri.edu> <1992Nov5.190151.2943@inmet.camb.inmet.com>
- Organization: UniSQL, Inc., Austin, Texas, USA
- Lines: 31
-
- In article <1992Nov5.190151.2943@inmet.camb.inmet.com> mazur@inmet.camb.inmet.com (Beth Mazur) writes:
- >The original poster thought she was prescribed depo provera "unofficially"
- >because she heard that the FDA had just approved the drug. I'm a bit
- >surprised that someone who "knows" (hey Steve!) hasn't responded, but here
- >is my two cents. I vaguely recall that the announcement last week was not
- >that the FDA had approved the drug, but that they were issuing warnings
- >about potential side-effects (which I assumed meant the drug had already
- >been approved for contraceptive purposes). However, this is just my
- >recollection based on a news blurb on the radio. I wasn't paying attention,
- >so I may be wrong :-).
-
- I'm the original poster. My "news source" was CNN. CNN stated that
- the drug had just been approved (so I assumed they meant within the last
- few days). The reporter also went on to say that the drug had been up
- for approval 20 years ago and that the feminist movement caused it to
- be "disapproved". (I thought that part of the story didn't make a lot
- of sense.)
-
- After hearing that the drug had just been approved, I wondered how I had
- been receiving it for several months. I didn't really _care_ how, I was
- just curious. :-)
-
-
-
- --
-
- ********************* #include <std_disclaimer.h> **********************
- * A. Collene Pearce (512-343-7372, x114) * Organization: UniSQL, Inc. *
- * * Austin, TX *
- * unisql!collene@cs.utexas.edu * 512-343-7297 or 7383(fax) *
- ************************************************************************
-